Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HERC2 pseudogene 1 (HERC2P1) is a human pseudogene, meaning it is a DNA segment similar to the HERC2 gene but thought to be non-functional or non-protein-coding. Pseudogenes are typically considered "genomic fossils" that arose from gene duplication or retrotransposition events. While HERC2 itself encodes an E3 ubiquitin ligase implicated in DNA repair and genome stability, HERC2P1 is not known to produce a functional protein and is not recognized as a therapeutic target. Some related pseudogenes in the HERC family (like HERC2P2) have been investigated for potential non-coding RNA functions in cancer biology, including biomarker roles, but there is no published evidence for such a role for HERC2P1. The nomenclature "D15F37S2" is an alternative, less frequently used synonym.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HERC2 pseudogene 1 (HERC2P1).